famciclovir

Brand: Famvir

Prototype: acyclovir
Drug Class: antiviral — penciclovir prodrug
Drug Family: antiviral
Subclass: oral prodrug of penciclovir
Organ Systems: infectious-disease

Mechanism of Action

Prodrug converted to penciclovir, which is phosphorylated by viral TK to penciclovir triphosphate; inhibits viral DNA polymerase with longer intracellular half-life than acyclovir triphosphate, potentially allowing less frequent dosing.

herpesvirus thymidine kinaseviral DNA polymerase

Indications

  • herpes zoster (shingles)
  • genital herpes — initial and recurrent episodes and suppression
  • herpes labialis (cold sores) in immunocompetent adults

Contraindications

  • famciclovir/penciclovir hypersensitivity

Adverse Effects

Common

  • headache
  • nausea
  • diarrhea
  • fatigue

Serious

  • nephrotoxicity (less common than acyclovir)
  • CNS effects (headache, confusion at high doses)

Pharmacokinetics (ADME)

Absorption 77% bioavailability; converted to penciclovir by first-pass deacetylation and oxidation
Distribution widely distributed; intracellular penciclovir triphosphate half-life 7–20 hours in infected cells
Metabolism rapidly deacetylated and oxidized to penciclovir in intestinal mucosa and liver
Excretion renal (73% as penciclovir)
Half-life 2–3 hours (penciclovir plasma); intracellular half-life much longer
Onset rapid
Peak 0.9 hours
Duration 8–12 hours (dosing intervals)
Protein Binding 20%
Vd moderate

Drug Interactions

Drug / Agent Mechanism Severity
probenecid reduces renal excretion of penciclovir; increased exposure minor
other nephrotoxic drugs additive nephrotoxicity potential moderate

Nursing Considerations

  1. Administer with or without food; initiate therapy promptly after symptom onset — within 72 hours for shingles, 24–48 hours for genital herpes for optimal efficacy.
  2. Reduce dose in renal impairment; monitor renal function with prolonged therapy.
  3. Counsel patients with genital herpes on safe sexual practices and that suppressive therapy reduces but does not eliminate shedding.
  4. Older patients with shingles should be counseled that antiviral therapy reduces both duration and severity of post-herpetic neuralgia if started promptly.

Clinical Pearls

  • Penciclovir triphosphate (the active form of famciclovir) has a markedly longer intracellular half-life (7–20 hours vs. 1 hour for acyclovir triphosphate), which is the pharmacological basis for famciclovir's more convenient dosing intervals.
  • For single-day treatment of cold sores (herpes labialis), famciclovir 1500 mg single dose has shown efficacy, offering a convenient option for patients.

Safety Profile

Pregnancy generally-safe
Lactation use-with-caution
Renal Adjustment Required
Hepatic Adjustment Not required
TDM Not required